Table 6 Treatments delivered during the 2 months preceding a major bleeding event after lung cancer diagnosis
| Â | Â | Total | Major bleeding type | ||
|---|---|---|---|---|---|
N (%) |  | (n = 341) | Digestive | Intracranial | Other |
Total | Â | Â | 55 (16.1) | 22 (6.5) | 264 (77.4) |
Anticoagulant or antiplatelet treatment | No | 172 (50.4) | 26 (47.3) | 8 (36.4) | 138 (52.3) |
| Â | Yes | 169 (49.6) | 29 (52.7) | 14 (63.6) | 126 (47.7) |
Anticoagulant therapy | No | 263 (77.1) | 40 (72.7) | 16 (72.7) | 207 (78.4) |
Yes | 78 (22.9) | 15 (27.3) | 6 (27.3) | 57 (21.6) | |
Antiplatelet therapy | No | 225 (66.0) | 37 (67.3) | 11 (50.0) | 177 (67.1) |
Yes | 116 (34.0) | 18 (32.7) | 11 (50.0) | 87 (32.9) | |
NSAID treatment | No | 312 (91.5) | 50 (90.9) | 19 (86.4) | 243 (92.1) |
Yes | 29 (8.5) | 5 (9.1) | 3 (13.6) | 21 (7.9) | |